Angiogenesis 2005, 8:373–379.PubMedCrossRef 11. Shigeto T, Yokoyama Y, Xin B, Mizunuma H: Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. Oncology Reports 2007, 18:833–840.PubMed 12. Vijay SK, Mishra M, Kumar H, Tripathi K: Effect of pioglitazone click here and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. Acta Diabetologica 2009, 46:27–33.PubMedCrossRef 13. Jin M, Saekusa Y, Dewa Y, Nishimura J, Matsumoto S, Shibutani M, Hasumi K, Mitsumori K: Hepatocarcinogenic

susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model. Archives of Toxicology 2009, 83:173–181.PubMedCrossRef 14. Chintalgattu V, Harris GS, Akula SA, Katwa LC: PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovascular Research 2007, 74:140–150.PubMedCrossRef 15. Suwaki N, Masuyama H, Masumoto A, Takamoto N, Hiramatsu Y: Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. Placenta 2007, 28:315–323.PubMedCrossRef 16. Yang HC, Ma LJ, Ma J, Fogo AB: Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte

injury-associated sclerosis. Kidney International find more 2006, 69:1756–1764.PubMedCrossRef 17. Tanaka T, Fukunaga Y, Itoh H, Doi K, Yamashita J, Chun TH, Inoue M, Masatsugu K, Saito T, Sawada N, et al.: Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. European Journal of Pharmacology 2005, 508:255–265.PubMedCrossRef 18. Emoto M, Anno T, Sato Y, Tanabe K, Okuya S, Tanizawa Y, Matsutani A, Oka Y: Troglitazone treatment increases plasma vascular endothelial growth Cilengitide cell line factor in diabetic Dapagliflozin patients and

its mRNA in 3T3-L1 adipocytes. Diabetes 2001, 50:1166–1170.PubMedCrossRef 19. Yamakawa K, Hosoi M, Koyama H, Tanaka S, Fukumoto S, Morii H, Nishizawa Y: Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications 2000, 271:571–574.PubMedCrossRef 20. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clinical Cancer Research 2005, 11:3974–3986.PubMedCrossRef 21. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735–745.PubMedCrossRef 22. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 1996, 16:4604–4613.